The global spinal biologics market is predicted to grow at a 3.75 percent compound annual growth rate, reaching $2.36 billion by 2021, according to a Research Cosmos report.
Here are three findings:
1. In 2013, the market was valued at $1.8 billion.
2. North America dominates the global spinal biologics market, with the U.S. leading the pack.
3. Key companies in the market include DePuy Synthes, NuVasive and Orthofix International.